This is a working overview of triple agonist, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2025-07-30. Anything still debated is marked as such rather than presented as settled.
瑞他鲁肽是一种在研合成肽,同时作用于胰高血糖素样肽-1、葡萄糖依赖性促胰岛素多肽和胰高血糖素受体。该分子属于多受体激动剂类别,尚未获得任何监管机构的上市批准。当前临床开发主要针对肥胖和2型糖尿病,研究代号为LY3437943。已确立的信息包括受体靶点和部分中期试验结果;最终疗效、长期安全性和适用人群仍属开放问题。
开发进程从早期单次和多次给药研究推进至大规模后期试验。公开报告显示,参与者在体重和相关代谢指标上出现变化,但完整数据需经同行评审并接受独立复核。试验设计通常包括随机、双盲和对照设置,以区分药物效应与行为干预。监管提交和标签范围尚未确定;长期维持效果与心血管结局仍是开放问题。
与仅靶向单一受体的同类药物相比,瑞他鲁肽增加胰高血糖素受体成分,理论上可提高能量消耗并改变脂肪分布。临床中观察到的体重变化是否主要来自该额外机制,目前尚无定论。胃肠道反应是该类药物常见不良事件,试验中通过剂量递增和监测进行管理。停药后体重反弹、个体差异和长期耐受性仍需更多数据。
Retatrutide is a synthetic peptide developed as a single molecule that activates three distinct hormone receptors: GLP-1, GIP, and glucagon. The compound carries the internal designation LY3437943 and was engineered by modifying the backbone of glucose-dependent insulinotropic polypeptide. Its sequence incorporates non-natural amino acids and a fatty acid side chain that extends circulation time. The triple-agonist design aims to combine appetite suppression, improved insulin response, and increased energy expenditure in one agent. Published reports describe it as an investigational product rather than an approved medicine.
Each receptor contributes a different physiological effect. Activation of the GLP-1 receptor slows gastric emptying and reduces appetite signaling in the brain. GIP receptor activity influences insulin secretion and lipid handling, while glucagon receptor stimulation raises energy use and fat oxidation. Combining these pathways is intended to produce weight loss beyond what single- or dual-receptor agonists achieve. Researchers attribute the observed potency to simultaneous engagement of all three targets, though the exact contribution of each receptor to overall effect remains under investigation.
Clinical development has advanced through phase 2 trials in adults with obesity and type 2 diabetes. Reported phase 2 results described substantial average weight reduction over roughly forty-eight weeks of weekly dosing. A phase 3 program is ongoing to confirm efficacy and assess long-term safety. Because the compound has not received regulatory approval, it is not available as a prescription product. Public discussion of retatrutide often conflates trial findings with marketed status, an important distinction when interpreting coverage of the topic.
| Property | Value | Notes |
|---|---|---|
| 研究代号 | LY3437943 | 文献中常用的实验标识 |
| 药物类别 | 三重受体激动剂 | 靶向GLP-1、GIP与胰高血糖素受体 |
| 开发状态 | 后期临床研究 | 尚未获批上市 |
| 主要研究人群 | 肥胖与2型糖尿病 | 入组条件依试验方案而定 |
| 常见同义词 | 瑞他鲁肽;LY3437943 | 名称拼写可能因语言和出版物而异 |
供应环节涉及来源核实与文件审核两类工作。分析证书、批次记录以及第三方检测报告构成常见的可追溯材料。来源不清的样品很难确认身份与纯度,因此核实步骤在实际操作中具有明确意义。缺少方法细节的报告通常无法复核。
多肽类化合物的表征通常依赖色谱与质谱联用技术。反相高效液相色谱用于评估纯度与有关物质,质谱用于确认分子量,肽图分析通过酶解碎片比对验证一级结构。这些手段组合使用,可以把目标产物与降解产物或类似物区分开来。单一方法往往不足以完成完整确认。
The intended pharmacology combines three signals in one molecule. GLP-1 receptor activation reduces appetite and slows gastric emptying, effects already exploited by approved incretin-based therapies. GIP receptor engagement is associated with improved insulin sensitivity and with direct effects on adipose tissue, although how much it contributes to overall outcomes is still debated. Glucagon receptor agonism raises energy expenditure and supports hepatic lipid handling, a mechanism that also tends to increase glucose output. The triple profile is hypothesized to produce a larger metabolic effect than single or dual agonism, but the relative weight of each receptor in humans is not settled.
Human evidence remains limited to controlled studies. A phase 2 trial in adults with obesity reported large, dose-dependent reductions in body weight over 48 weeks, with gastrointestinal events as the most frequently recorded adverse effect. Phase 3 programs designated TRIUMPH, for obesity, and TRANSCEND, for type 2 diabetes, are intended to confirm efficacy and to characterize safety in larger populations. Related studies are examining conditions such as knee osteoarthritis in people with obesity and metabolic liver disease. Open questions include long-term tolerability, effects on lean mass, and what happens after treatment is stopped.
The above explanation is merely a simple introduction to vacuum pumping, and is not representative of the entire range of pumps in use. Many variations of the positive displacement pump have been developed, and many other pump designs rely on fundamentally different principles. Momentum transfer pumps, which bear some similarities to dynamic pumps used at higher pressures, can achieve much higher quality vacuums than positive displacement pumps. Entrapment pumps can capture gases in a solid or absorbed state, often with no moving parts, no seals and no vibration. None of these pumps are universal; each type has important performance limitations. They all share a difficulty in pumping low molecular weight gases, especially hydrogen, helium, and neon. The lowest pressure that can be attained in a system is also dependent on many things other than the nature of the pumps. Multiple pumps may be connected in series, called stages, to achieve higher vacuums. The choice of seals, chamber geometry, materials, and pump-down procedures will all have an impact. Collectively, these are called vacuum technique. And sometimes, the final pressure is not the only relevant characteristic. Pumping systems differ in oil contamination, vibration, preferential pumping of certain gases, pump-down speeds, intermittent duty cycle, reliability, or tolerance to high leakage rates. In ultra high vacuum systems, some very "odd" leakage paths and outgassing sources must be considered.
== T == Celia White Tabor (1918–2012). American biochemist at the NIH, expert on the biosynthesis of polyamines. Herbert Tabor (1918–2020). American biochemist at NIH who studied the function of polyamines and their role in human health and disease. He was editor-in-chief of the Journal of Biological Chemistry for nearly 40 years. Member Natl. Acad. Sci. USA. Charles Tanford (1921–2009). American protein chemist at Duke University, known for analysis of the hydrophobic effect. Member Natl. Acad. Sci. USA. Ignacio Tinoco Jr. (1930–2016). American chemist at UC Berkeley, known for his pioneering work on RNA folding. Member Natl. Acad. Sci. USA. Arne Tiselius FRS (foreign associate) (1902–1971). Swedish biochemist at the University of Uppsala, who developed protein electrophoresis. Nobel Prize for Chemistry (1948). Foreign associate Natl. Acad. Sci. USA. Victor Trikojus CBE (1902–1985). Australian biochemist, head of the School of Biochemistry at the University of Melbourne (1943–1968). Joint discoverer of triiodothyronine (T3) with Frank Hird in 1948. Chen-Lu Tsou (邹承鲁 Zou Chenglu in Pinyin, 1923–2006). Chinese biochemist at the Academia Sinica, known for work on enzyme inactivation kinetics, and even more as the "face of Chinese biochemistry" for many years in the west. Member of the Academia Sinica.
The Furman is a unit of angular measure equal to 1⁄65,536 of a circle, or just under 20 arcseconds. It is named for Alan T. Furman, the American mathematician who adapted the CORDIC algorithm for 16-bit fixed-point arithmetic sometime around 1980. 16 bits give a resolution of 216 = 65,536 distinct angles. A related unit of angular measure equal to 1⁄256 of a circle, represented by 8 bits, has found some use in machinery control where fine precision is not required, most notably crankshaft and camshaft position in internal combustion engine controllers, and in video game programming. There is no consensus as to its name, but it has been called the 8-Bit Furman. These units are convenient because binary integer overflow resembles angular arithmetic: the value of an 8-bit integer overflows from 255 to 0 when a full circle has been traversed. This means binary addition and subtraction work as expected for angular arithmetic. Measures are often made using a Gray code, which is trivially converted into more conventional notation. Its value is equivalent to about 0.0245 radians or 1.41°.
Sources: en.wikipedia.org
Features of the Early Lesion: Accentuation of features of the initial lesion, such as the considerably greater loss of collagen Accumulation of lymphocytes subjacent to junctional epithelium Cytopathic alterations in resident fibroblasts Preliminary proliferation of basal cells of junctional epithelium
Nitric acid (HNO3) is by far the most important and the most stable of the nitrogen oxoacids. It is one of the three most used acids (the other two being sulfuric acid and hydrochloric acid) and was first discovered by alchemists in the 13th century. It is made by the catalytic oxidation of ammonia to nitric oxide, which is oxidised to nitrogen dioxide, and then dissolved in water to give concentrated nitric acid. In the United States of America, over seven million tonnes of nitric acid are produced every year, most of which is used for nitrate production for fertilisers and explosives, among other uses. Anhydrous nitric acid may be made by distilling concentrated nitric acid with phosphorus pentoxide at low pressure in glass apparatus in the dark. It can only be made in the solid state, because upon melting it spontaneously decomposes to nitrogen dioxide, and liquid nitric acid undergoes self-ionisation to a larger extent than any other covalent liquid as follows:
In mid-2010, the Obama administration issued sanctions against the Government of Syria relating to charges of state-sponsored terrorism and weapons of mass destruction development. In November, Akram Elias flew to Damascus. He met with Bouthaina Shaaban, an aide to Bashar al-Assad, to assist the Syrian regime in developing a public relations strategy to repair Syria's damaged image in Washington. He was paid $22,000 a month for his services. At around the same time that Elias was working for the Syrians, Capital Communications Group maintained contracts with USAID, the Department of Justice, Department of State, Drug Enforcement Administration, and Department of Homeland Security, among other federal agencies. In 2010, USAID launched ZunZuneo, a social media network designed for Cuba. The intent of the right-wing USAID officials who hatched the scheme, according to documents uncovered by the Associated Press, was to create "smart mobs," that would overthrow the government of Cuba. The United States diplomatic cables leak occurred on Wikileaks around this time, and Collera Venta's cover was blown. Without being able to work in intelligence anymore, he left the State Security Unit to focus full time on his career as a cardiologist.
Sources: en.wikipedia.org
尚未。它仍处于临床研究阶段,任何监管批准都取决于正在进行的试验结果和提交审评。可公开获取的信息以试验注册和会议摘要为主。
司美格鲁肽主要靶向GLP-1受体,而瑞他鲁肽同时作用于GLP-1、GIP和胰高血糖素受体。这种三重机制旨在产生不同的代谢效应,但临床差异仍需头对头研究确认。
长期心血管结局、停药后维持效果、罕见不良事件和不同人群中的获益风险比尚未完全确定。完整三期数据和监管审评将影响结论。
Retatrutide is an investigational peptide that activates the GLP-1, GIP, and glucagon receptors at the same time. It is being studied for obesity and type 2 diabetes and has not been approved for clinical use. The internal code LY3437943 refers to the same molecule.